ALEXANDRIA, Va., July 23 -- United States Patent no. 12,365,711, issued on July 22, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).
"TGFBeta signal convertor" was invented by Benjamin Boyerinas (Brookline, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides improved compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated therewith."
The patent was filed on April 7, 2023, under Application No. 18/297,491.
*For further information, including images, charts and tables, please visit: http://p...